Notes
National Health Service
2015 British pounds
Reference
Hunt B, et al. Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom. Diabetes Therapy 8: 129-147, No. 1, Feb 2017. Available from: URL: http://doi.org/10.1007/s13300-016-0219-2
Rights and permissions
About this article
Cite this article
Once-daily liraglutide cost effective for T2DM in the UK. PharmacoEcon Outcomes News 773, 27 (2017). https://doi.org/10.1007/s40274-017-3812-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3812-3